Lise Kjems
Crinetics Pharmaceuticals (United States)(US)
Publications by Year
Research Areas
Drug Transport and Resistance Mechanisms, Pediatric Hepatobiliary Diseases and Treatments, Diabetes Management and Research, Liver Diseases and Immunity, Diabetes Treatment and Management
Most-Cited Works
- → The Influence of GLP-1 on Glucose-Stimulated Insulin Secretion(2003)577 cited
- → Odevixibat treatment in progressive familial intrahepatic cholestasis: a randomised, placebo-controlled, phase 3 trial(2022)160 cited
- → Treatment of patients with cardiovascular disease with L-4F, an apo-A1 mimetic, did not improve select biomarkers of HDL function(2010)148 cited
- → Postprandial Suppression of Glucagon Secretion Depends on Intact Pulsatile Insulin Secretion(2006)144 cited
- → Overnight inhibition of insulin secretion restores pulsatility and proinsulin/insulin ratio in type 2 diabetes(2000)133 cited
- → Improved postprandial glycaemic controls with insulin Aspart in type 2 diabetic patients treated with insulin(2000)113 cited
- → Decrease in β-Cell Mass Leads to Impaired Pulsatile Insulin Secretion, Reduced Postprandial Hepatic Insulin Clearance, and Relative Hyperglucagonemia in the Minipig(2001)111 cited
- → Signal Epitopes in the Three‐Dimensional Structure of Neuropeptide Y(1990)99 cited
- → Skeletal Muscle Mitochondrial Capacity and Insulin Resistance in Type 2 Diabetes(2011)81 cited
- → Validation of methods for measurement of insulin secretion in humans in vivo.(2000)80 cited